Hansa Biopharma AB (publ) (STO: HNSA)
Sweden
· Delayed Price · Currency is SEK 30.60
+0.62 (2.07%)
Nov 20, 2024, 5:29 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 2.08 billion as of November 21, 2024. Its market cap has increased by 53.96% in one year.
Market Cap
2.08B
Enterprise Value
2.48B
Revenue
189.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.60
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 2.08B, an increase of 6,656.62%. That is a compound annual growth rate of 28.92%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 2,158.07B |
| Swedish Orphan Biovitrum AB (publ) | 99.53B |
| Sectra AB (publ) | 52.53B |
| Getinge AB (publ) | 45.40B |
| Camurus AB (publ) | 32.34B |
| Vitrolife AB (publ) | 28.41B |
| Medicover AB (publ) | 26.03B |
| Elekta AB (publ) | 23.73B |